These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - A case report. Kavita A; Abdul Onny MA; Suppiah S; Abdul Aziz AF; Hashim H; Raja Shariff RE; Ng CS Med J Malaysia; 2021 Sep; 76(5):762-767. PubMed ID: 34508392 [TBL] [Abstract][Full Text] [Related]
3. Multimodality Imaging in the Diagnosis and Assessment of Cardiac Amyloidosis. Velaga J; Liew C; Choo Poh AC; Lee PT; Lath N; Low SC; Bharadwaj P World J Nucl Med; 2022 Sep; 21(3):173-183. PubMed ID: 36060088 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis and Evaluation of Cardiac Amyloidosis with Noninvasive Multimodality Imaging. Wang J; Wang Y; Ren S; Chen Y; Chu H; Pang Z; Li J Int Heart J; 2022 Nov; 63(6):1194-1200. PubMed ID: 36372411 [TBL] [Abstract][Full Text] [Related]
5. Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution. Poterucha TJ; Elias P; Bokhari S; Einstein AJ; DeLuca A; Kinkhabwala M; Johnson LL; Flaherty KR; Saith SE; Griffin JM; Perotte A; Maurer MS JACC Cardiovasc Imaging; 2021 Jun; 14(6):1221-1231. PubMed ID: 33221204 [TBL] [Abstract][Full Text] [Related]
12. Novel Tracers for the Imaging of Cardiac Amyloidosis. Shetty M; Malhotra S J Nucl Med Technol; 2023 Jun; 51(2):120-124. PubMed ID: 37192820 [TBL] [Abstract][Full Text] [Related]
13. Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis. Bistola V; Parissis J; Foukarakis E; Valsamaki PN; Anastasakis A; Koutsis G; Efthimiadis G; Kastritis E Heart Fail Rev; 2021 Jul; 26(4):861-879. PubMed ID: 33452596 [TBL] [Abstract][Full Text] [Related]
14. Advancements and challenges in cardiac amyloidosis imaging: A comprehensive review of novel techniques and clinical applications. Albulushi A; Al Hajri R; Hovseth C; Jawa Z; El Hadad MG; Sallam M; Al-Mukhaini M Curr Probl Cardiol; 2024 Jun; 49(9):102733. PubMed ID: 38955249 [TBL] [Abstract][Full Text] [Related]
15. Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis. Martini N; Rizzo S; Sarais C; Cipriani A BMC Cardiovasc Disord; 2020 Oct; 20(1):466. PubMed ID: 33121442 [TBL] [Abstract][Full Text] [Related]
17. Value of nuclide scintigraphy in the diagnosis and prognosis of cardiac amyloidosis. Mo Q; Deng Z; Xiao Y; Liu C; Zhao M Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 48(11):1739-1745. PubMed ID: 38432865 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis. Galat A; Rosso J; Guellich A; Van Der Gucht A; Rappeneau S; Bodez D; Guendouz S; Tissot CM; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Itti E; Meignan M; Damy T Amyloid; 2015; 22(4):210-20. PubMed ID: 26465835 [TBL] [Abstract][Full Text] [Related]
19. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable. Rubin J; Maurer MS Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086 [TBL] [Abstract][Full Text] [Related]